RPG Life Sciences: Notice on Transfer of Equity Shares to IEPF Account
RPG Life Sciences is transferring unclaimed shares to the IEPF Account. Shareholders with unclaimed dividends since FY 2018-19 must claim them by September 01, 2026. Failure to do so will result in share transfer to IEPF. The company has published notices and updated its website with relevant details.
This is a standard procedural announcement related to unclaimed dividends and shares, which is a common regulatory requirement and typically has a minimal impact on the company's operations or market perception.
The announcement is a routine regulatory compliance measure regarding unclaimed dividends and shares, with no immediate positive or negative financial implications for the company.
RPG Life Sciences Limited has issued a notice regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Account. This action is in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 124(6) of the Companies Act, 2013, read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The company has sent intimations to shareholders whose dividends have remained unclaimed for seven consecutive years or more, specifically from FY 2018-19 onwards. These shareholders are requested to claim their unpaid dividends from the company by contacting its Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The deadline for claiming the dividend is Tuesday, September 01, 2026.
If no claim is received by this date, the company will be mandated to transfer the corresponding shares to the IEPF Account without further notice. For shareholders holding shares in physical form, duplicate share certificates will be issued for the transfer, and the original certificates will be automatically cancelled. For those holding shares in dematerialized form, the shares will be debited from their respective demat accounts. Shareholders can claim their shares and dividends from the IEPF Authority after following the prescribed procedure using Form IEPF-5 available on the IEPF website.
Notices regarding this matter were also published in Business Standard (English) and Mumbai Lakshwadeep (Marathi) on June 03, 2026. The company has also uploaded the list of shareholders whose shares are liable for transfer to the IEPF Authority on its website, www.rpglifesciences.com, under the "Investor Tab". Shareholders are urged to ensure their PAN, bank details, and contact information are updated with the Registrar and Transfer Agent for better servicing.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.